Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs
- Alyson Haslam
- , Vinay Prasad
Research output: Contribution to journal › Article › peer-review
1170
Link opens in a new tab
Scopus
citations